Physician profile
David Stuart Jencks
NPI 1700175635
$1,365.28
in general payments reported to CMS, 2019-2025
19 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $57.01 · 2021: $163 · 2022: $309 · 2023: $230 · 2024: $337 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $503.41 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $137.46 | 2020-2024 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $100.67 | 2021-2024 | Entyvio |
| Boston Scientific Corporation | $83.46 | 2024 | |
| Braintree Laboratories, INC. | $80.76 | 2019-2024 | Sutab, Suflave |
| Genzyme Corporation | $77.24 | 2022-2025 | |
| Pfizer INC. | $71.98 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.29 | 2020-2022 | |
| Biofire Diagnostics, LLC | $68.05 | 2019 | |
| Celgene Corporation | $23.81 | 2024 | Zeposia |
| Echosens North America, INC. | $20.01 | 2019 | |
| Lilly USA, LLC | $17.02 | 2024 | Omvoh |
| Ardelyx, INC. | $16.97 | 2023 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $16.84 | 2025 | Dupixent |
| Organon LLC | $16.24 | 2023 | Renflexis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $16.14 | 2021 | |
| Amgen INC. | $16.03 | 2021 | |
| Merck Sharp & Dohme LLC | $15.54 | 2023 | Dificid |
| Janssen Biotech, INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jencks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.